NLRP3 MODULATORS

The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).

Saved in:
Bibliographic Details
Main Authors Gavai, Ashvinikumar V, ZHANG, Yong
Format Patent
LanguageEnglish
Published 14.10.2021
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds of Formula (I): wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
Bibliography:Application Number: US201917267516